Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report.
Green
M R
MR
Cox
J D
JD
Ardizzoni
A
A
Arriagada
R
R
Bureau
G
G
Darwish
S
S
Deneffe
G
G
Fukuoka
M
M
Joseph
D
D
Komaki
R
R
D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D009367:Neoplasm Staging